The Pancreatic Cancer Action Network (PanCAN) is seeking applicants for its 2019 research grant program that is open to scientists who are working to advance pancreatic cancer research. The competitive program provides grants of $500,000 through two submission categories: the Catalyst Grant, and the Translational Research Grant.
The Catalyst Grant provides $500,000 over three years, and requires candidates to be junior faculty members. Applicants also must have a project with direct applicability to pancreatic cancer and can be clinical, translational, epidemiological, or basic in nature.
The Translational Research Grant gives the total $500,000 over a two-year term instead, and is designed for high-priority pancreatic cancer research projects. Proposals for this grant need to identify novel approaches and targets in the treatment of pancreatic cancer.
PanCAN works to increase the number of young investigators combatting the disease, a longstanding commitment. Both of these grants, as well as PanCAN’s other initiatives, hope to double the survivability of pancreatic cancer by 2020.
“The need for continued research funding, both public and private, is urgent, as pancreatic cancer patients have the lowest five-year survival rate of any major cancer at just 9 percent,” said PanCAN’s chief science officer, Lynn Matrisian, PhD, MBA in a press release. “Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States around 2020. Every new advance in detection or treatment began as a research effort.”
